NEW YORK (GenomeWeb News) – Private equity group Argos Soditic and management members of Cisbio Bioassays today announced that they have acquired Cisbio Bioassays from IBA for an undisclosed amount.

As a result, Cisbio will operate as an independent company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.